Home

Sample preparation techniques for synthetic benzodiazepines

By Biotage

Introduction


Synthetic benzodiazepines are becoming more abused and are considered “legal highs”. Many forensic laboratories are finding more and more of these compounds in post-mortem and impairment cases. While synthetic benzodiazepine prevalence has not been widely broadcast as it is overshadowed by the opioid epidemic, this drug class is now the fourth most commonly identified illegal synthetic drug class, after synthetic cannabinoids, synthetic opioids, and synthetic cathinone (https://ndews. umd.edu/resources/dea-emerging-threat-reports).

Analytes


Clobazam, bromazepam, phenazepam, estazolam, clonazolam, prazepam, flubromazepam, etizolam, delorazepam, pyrazolam, diclazepam, nimetazepam

biotage-an932-figure1-Typical-workflow-ISOLUTE®-SLE+

Figure 1: Typical workflow for ISOLUTE® SLE+

 

Methods


There are several different extraction methods that can be used to extract synthetic benzodiazepines from biological matrices such as urine and blood. This application note evaluates three common extraction techniques, detailing the methodology used, and comparing results in terms of analyte recovery and matrix effects.
One technique is supported liquid extraction using ISOLUTE® SLE+. This product, available in plate or cartridge format, employs the mechanism of a liquid-liquid extraction with a diatomaceous earth sorbent, allowing for complete separation of the aqueous and organic layers (see Figure 1).
The first step is loading samples onto the diatomaceous earth material. A five-minute wait time allows the aqueous sample to fully adsorb onto the sorbent. Next, an elution step follows using a water-immiscible organic solvent like dichloro- methane (DCM), ethyl acetate (EA), or MTBE (tert-butyl methyl ether). This step targets the compounds of interest allowing them to elute off of the diatomaceous earth sorbent, while leaving behind any aqueous impurities and other unwanted components.

Solid Phase Extraction (SPE) can also be used to isolate the synthetic benzodiazepine compounds. EVOLUTE® EXPRESS CX, a polymeric sorbent, was used for these compounds.
This technique utilizes a mixed-mode mechanism (non-polar interactions and cation exchange) to allow for additional sample cleaning without loss of analyte recovery. The polymeric sorbent is water-wettable, which permits the exclusion of the condition and equilibration steps and promotes less pre-elution plate drying time (see Figure 2).

biotage-an932-figure2-Typical-workflow-solid-phase-extraction-using-EVOLUTE®-EXPRESS
Figure 2: Typical workflow for solid phase extraction using EVOLUTE® EXPRESS.

Dual Mode Extraction (DME) using ISOLUTE® HYDRO DME+ is the simplest technique for extraction. This product, available in plate or cartridge format, uses two scavenging layers of sorbent to remove components of biological matrices, including pigments, salts, urea, and creatinine (see Figure 3).

biotage-an932-figure3-Typical-workflow-ISOLUTE-HYDRO-DME+

Figure 3: Typical workflow for ISOLUTE® HYDRO DME+.

 

The methods used for extraction of the synthetic benzodiazepine compounds from whole blood and urine samples are shown below. The samples can be extracted manually using a Biotage® VacMaster™ 96 or Biotage® Pressure+ 96. The extractions can also be automated using the Biotage® Extrahera Automated Sample Preparation System.

Sample volume

100 µL

Pretreatment

100 µL 1% NH4OH (aqueous)

Load sample Elution

2 x 750 µL dichloromethane OR

 

2 x 750 µL ethyl acetate OR

2 x 750 µL MTBE OR

2 x 750 µL 95:5

 

dichloromethane/isopropanol


Following elution, evaporate samples to complete dryness using a Biotage® SPE Dry 96 plate evaporator. Reconstitute in 100 µL 95:5 mobile phase A/mobile phase B.

Urine sample volume

100 µL

Pretreatment

100 µL 0.1% formic acid (aqueous)

Extraction

 

Condition

NONE

Equilibrate

NONE

Load

 

Wash 1

1 mL water

Wash 2

1 mL 0.1% formic acid (aq)

Wash 3

1 mL methanol OR 50:50 methanol/water

Plate Dry

1 min at 20 psi

Elution

2 x 750 µL 78:20:2 DCM/IPA/NH4OH OR 2 x 750 µL 78:20:2 EA/ACN/NH4OH

 

After elution, evaporate samples to complete dryness using a Biotage® SPE Dry 96 plate evaporator. Reconstitute in 100 µL 95:5 mobile phase A/mobile phase B.

 

Sample volume

100 µL

Load sample

OPTIONAL

Add 10 µL formic acid to sample

Add Acetonitrile

600 µL

Mix

Pipette mix 5 times

Elution

Push sample through sorbent

 

Following elution, evaporate samples to complete dryness using a Biotage® SPE Dry 96 plate evaporator. Reconstitute in 100 µL 95:5 mobile phase A/mobile phase B.

 

Analytical conditions


For all samples, following evaporation and reconstitution as described, LC-MS/MS analysis was performed using the conditions outlined below.

LC parameters


Instrument


Shimadzu Nexera X2


LC column


Restek Raptor Biphenyl 50 x 3 mm, 2.7 µm (Cat # 9309A52)


Column temperature


40°C


Mobile phase A:


0.1% formic acid in water


Mobile phase B:


0.1% formic acid in methanol

Time

% Mobile phase B

0.01

5

0.5

10

5.25

70

7.5

95

7.7

95

7.75

5

9.25

STOP

 

Flow rate


0.4 mL/min


Run time


9.25 minutes


Injection volume


2.5 µL

 

MS/MS parameters


Instrument


SCIEX 5500 Triple Quadrupole


Source gas


600 ⁰C


Curtain gas


30


Collision gas (CAD)


8


Ionspray voltage


1500 V


Ion source gas 1


50


Ion source gas 2


50


Entrance potential


10


Positive polarity


Table 3 shows the MS parameters for each compound in the panel

 

Compound

Retention time

Q1

Q3

Declustering Potential

Collision Energy

CXP

Clobazam

6.74

300.951

259.1

136

31

6

 

 

300.951

224.1

136

45

10

Bromazepam

6.74

317.929

301.0

16

13

8

 

 

317.929

259.0

16

35

16

Phenazepam

6.71

348.917

206.1

21

47

12

 

 

348.917

184.1

21

41

8

Estazolam

6.86

295.000

267.0

96

33

4

 

 

295.000

205.2

96

55

14

Clonazolam

6.57

353.962

308.1

181

37

14

 

 

353.962

280.1

181

49

8

Prazepam

7.73

324.992

271.1

216

33

10

 

 

324.992

140.1

216

47

10

Flubromazepam

6.57

334.904

226.1

66

39

12

 

 

334.904

185.9

66

41

12

Etizolam

7.34

342.955

314.1

216

35

6

 

 

342.955

259.1

216

47

8

Delorazepam

6.58

304.946

166.0

121

71

8

 

 

304.946

140.2

121

71

26

Pyrazolam

6.51

355.938

206.2

156

47

12

 

 

355.938

167.2

156

65

16

Diclazepam

7.15

318.927

154.1

141

39

10

 

 

318.927

227.2

141

47

6

Nimetazepam

6.94

296.000

250.1

126

35

8

 

 

296.000

221.2

126

47

8

 

Results


For every method, a 10 ng/mL and a 100 ng/mL sample were run to ensure consistency over a concentration range.
The recoveries and matrix effects shown are using a 10 ng/mL sample in whole blood or urine. When analysing urine samples (Figure 4), the highest recoveries were obtained when using ISOLUTE® SLE+ with an ethyl acetate elution solvent. When using EVOLUTE® EXPRESS CX with a 100% methanol wash, bromazepam and clobazam were mostly washed away. ISOLUTE® HYDRO DME+ when used without formic acid had recoveries of 60–75% for all compounds.

biotage-an932-figure4-recoveries-synthetic-benzodiazepines-urine

Figure 4. Recoveries of synthetic benzodiazepines from urine samples

biotage-an932-figure5-recoveries-synthetic-benzodiazepines-blood

Figure 5. Recoveries of synthetic benzodiazepines from whole blood samples


When analysing whole blood samples (Figure 5), the highest recoveries were obtained when using ISOLUTE® SLE+ with an MTBE or an ethyl acetate elution solvent. ISOLUTE® HYDRO DME+ when used with formic acid only resulted in recoveries of 10–20% for all compounds. Without using formic acid, recoveries were between 35–50% for all compounds.

When looking at matrix effects of urine samples (Figure 6), ISOLUTE® HYDRO DME+ with formic acid resulted in the most suppression (dirtiest extracts). The cleanest extracts (least suppression) was seen when extracting with ISOLUTE® SLE+ using a dichloromethane or dichloromethane/isopropanol elution solvent or EVOLUTE® EXPRESS CX with a 50% methanol wash and an EA/ACN/NH4OH elution solvent.

 

biotage-an932-figure6-matrix-effects-synthetic-benzodiazepines-urine
Figure 6. Matrix effects of synthetic benzodiazepines from urine samples.

 

When looking at matrix effects of whole blood samples (Figure 7), the dirtiest extracts were seen when extracting using ISOLUTE® SLE+ with an MTBE elution solvent. Surprisingly, extracting using ISOLUTE® HYDRO DME+ resulted in the cleanest extracts (least suppression).

biotage-an932-figure7-matrix-effects-synthetic-benzodiazepines

Figure 7: Matrix effects of synthetic benzodiazepines from whole blood

 

Conclusion


There are several different extraction techniques that can be used to extract synthetic benzodiazepines from whole blood and urine samples. It is important to consider the compounds in the panel, the desired extract cleanliness, compound recoveries, and extraction time to determine which method best fits the application. If use of the same extraction technique for both whole blood and urine samples is desired, ISOLUTE® SLE+ using an ethyl acetate elution solvent results in recoveries over 75% and slight suppression for some compounds.

 

Literature number: AN932

Related literature